Hanne Struyfs, Phd, Pmp Email & Phone Number

Antwerp, Be

Antwerp, Be

Beerse, Flemish Region, Belgium

GPH R&D programs tackle diseases for which the patients are primarily living in low- and middle-income countries. Executing trials in resource-limited settings (RLS) are subject to increased risks and challenges compared to running these trials in Western world. The GPH R&D Capacity Development Group (CDG) addresses and mitigates these increased risks using a multipronged approach. In my role, I supported the CDG team in strategy development and portfolio alignment and management, managing the major initiatives, coordinating and leading the grant writing for a key initiative - which resulted in obtaining the 1M EUR grant, managing the key projects, creating and managing communication tools and materials, managing the budget, following up on G&Os, and being the POC for related functions (communications, PMO, and finance).

Temse

Modis is a community made up of the world’s brightest minds in Life Sciences, IT and Engineering. Our Professionals have the skills and passion to answer the complex challenges of doing business in today’s dynamic world. Innovative technologies are transforming the way we perform research, develop and market new products, deliver care, communicate with patients, and adhere to regulations. Our mission in life sciences is to help our clients improve their customers’ and patients’ quality of life. We can count on the expertise of hundreds of life sciences consultants experienced in drug development, product marketing and patient care.

Brussels Area, Belgium

Post Doc - Clinical diagnosis for Alzheimer's diseaseClinical validation of imaging pipelines for dementia.---------------------------------------------------------icometrix - Transforming patient care through imaging AI. icometrix (Leuven, Belgium; Chicago, USA) is the world leader in software solutions to obtain clinically meaningful data from brain MRI and CT scans for patients with Multiple Sclerosis, Traumatic Brain Injury, Epilepsy, Alzheimer’s Disease, Stroke, etc. The fully automated icobrain software is FDA approved and has market approval in Europe, Japan, Canada, South America and Australia. Today, icometrix is internationally active, the icobrain software is used in 100+ hospitals and icometrix works with the largest pharmaceutical and health tech companies.

As a PhD researcher I contributed to the field of biomarker-based diagnosis and prognosis for Alzheimer's disease. After I acquired an IWT Baekeland fellowship in October 2014 I started managing a 4-year multidisciplinary and collaborative project with industry and academic partners. During the time of the project I was an employee of icometrix and external employee of ADx NeuroSciences and theUniversity of Antwerp. I performed all the steps of the study, from interacting with the 3 collaboratinghospitals, recruiting over 150 patients and healthy controls, designing study outlines, performing quality control of data and (statistical) data analyses, being responsible for time- and data management, reporting study results (4 oral, of which 1 invited, and 10 poster presentations and 4 first-author publications), and bridging communication between different stakeholders. Besides this dedicated project, I also supervised data management of over 25+ national and European collaborations (resulting in 28 publications and 44 conference abstracts), coordinated clinical investigations at hospitals, coordinated lab work (ELISAs), adapted standard operating procedures (SOPs) according to new European guidelines and implemented them in daily lab routine, and supervised 5 students during internships.

Montreal, Canada Area

Lab: Translational Neuroimaging Laboratory - McGill Centre for Studies in AgingSupervisor: Prof. dr. Pedro Rosa-NetoDuring this 6-month research stay I performed a head-to-head comparison of biological markers of Alzheimer's disease which required advanced multivariate statistics on a large dataset. I was also involved in studies on new advanced methodologies for quantifying neurodegenerative processes on PET.--------------------------------------------------------------------------------Translational Neuroimaging Laboratory (TNL) develops neuroimaging techniques and analytical frameworks for modeling neurodegenerative processes including deposition of protein aggregates, metabolic abnormalities, cell transport systems and neuroreceptors dysfunction. The laboratory encompasses a cohesive multidisciplinary team conducting integrative and multimodal neuroimaging research in human disease as well as disease models. TNL collaborates with an extensive network of laboratories and is committed to scientific training in the field of neuroimaging.

Antwerp Area, Belgium

Lab: Antwerp University Research Center for Equilibrium and Aerospace (AUREA)Title: Comparison of the ocular Vestibular Evoked Myogenic Potentials (oVEMP) test and the Unilateral Centrifugation (UC) test for utricle assessment in patients with specific vestibular lesions.Supervisors: Prof. dr. Floris Wuyts and dr. Aurélie Weerts- Perform clinical vestibular tests (c-VEMP, o-VEMP and UC) on patients with regard to diagnosis and on healthy subjects in order to validate and calibrate the oVEMP test

Limburg Area, Belgium

Lab: Functional MorphologyTitle: Neuromodulation: interindividual variation of the cerebrospinal fluid layer at thoracic level and its impact on spinal cord stimulation in patients with chronic back pain.Supervisors: Prof. dr. Koos Jaap Van Zwieten and dr. Wim Duyvendak- Dissection of human bodies to uncover the spinal cord and to perform comparative measurements on the spinal cord- Visual rating of MRI data

Strategy Excellence

Doctor Of Philosophy - Phd

Master'S Degree, Biomedical Sciences, Neurosciences

Bachelor'S Degree, Biomedical Sciences, General

Science & Mathematics

Education record